Results 51 to 60 of about 160,518 (194)

Bronchiectasis as an Underrecognized Extraintestinal Manifestation of Inflammatory Bowel Disease

open access: yesJCC Plus, Volume 1, Issue 5, September 2026.
ABSTRACT Introduction Inflammatory bowel diseases (IBD) are chronic inflammatory diseases of the gastrointestinal tract, often presenting with extraintestinal manifestations (EIMs). The most prevalent pulmonary EIM is IBD‐associated bronchiectasis (IBD‐BE), which is often overlooked.
Lynn te Slaa   +2 more
wiley   +1 more source

Clinical Outcomes of Chronic Airway Infection in Primary Ciliary Dyskinesia

open access: yesPediatric Pulmonology, Volume 61, Issue 9, September 2026.
ABSTRACT Introduction Primary ciliary dyskinesia (PCD) is a rare disorder of impaired respiratory mucociliary clearance and chronic pulmonary infections. The clinical impact of chronic infection is poorly understood. The objective of this single‐center, retrospective cohort study was to assess clinical outcomes of people with PCD and chronic airway ...
Thomas G. Saba   +3 more
wiley   +1 more source

Allergic bronchopulmonary aspergillosis manifesting as recurrent pneumonia in an adolescent: a case report

open access: yes, 2020
Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder caused by hypersensi- tivity to Aspergillus fumigatus. The diagnosis is based on sensitization to Aspergillus, associated with clinical, immunological and radiological ...
Arturi, Elisa   +6 more
core   +1 more source

Impact of Aspergillus fumigatus in allergic airway diseases

open access: yesClinical and Translational Allergy, 2011
For decades, fungi have been recognized as associated with asthma and other reactive airway diseases. In contrast to type I-mediated allergies caused by pollen, fungi cause a large number of allergic diseases such as allergic bronchopulmonary mycoses ...
Chaudhary Neelkamal, Marr Kieren A
doaj   +1 more source

Pediatric Pulmonary and Thoracic Aspergillosis

open access: yesSiriraj Medical Journal, 2020
Aspergillus infection can cause significant disease in an immunocompromised host and lungs are the most common site of infection. Various forms of aspergillus involving lung parenchyma have been described including aspergilloma, allergic bronchopulmonary
Preeyacha Pacharn   +3 more
doaj  

Recurrent Asthma Exacerbations Secondary to Gastric Stenosis After Gastric Band Slippage: Case Report and Literature Review

open access: yesRespirology Case Reports, Volume 14, Issue 9, September 2026.
We present a patient with long‐standing severe Type 2 asthma complicated by recurrent exacerbations of an infective nature that was ultimately found to be associated with gastric band slippage causing gastric stenosis and delayed gastric emptying. Exacerbations ceased after surgical intervention and removal of the band.
Gerardo Arwi   +2 more
wiley   +1 more source

Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Isavuconazole: Case Report and Review of the Literature

open access: yes, 2017
Isavuconazole is a new triazole that is approved for primary therapy of invasive aspergillosis. We provide the first report of a patient with allergic bronchopulmonary aspergillosis (ABPA) who was successfully treated with isavuconazole with marked ...
Thomas J. Walsh   +3 more
core   +1 more source

Lung and gut microbiomes in pulmonary aspergillosis: Exploring adjunctive therapies to combat the disease

open access: yesFrontiers in Immunology, 2022
Species within the Aspergillus spp. cause a wide range of infections in humans, including invasive pulmonary aspergillosis, chronic pulmonary aspergillosis, and allergic bronchopulmonary aspergillosis, and are associated with high mortality rates.
Liuyang Cai   +14 more
doaj   +1 more source

IL‐33 Drives Inflammatory Changes and Extracellular Trap Formation in Eosinophils Involving Oxidised LDL and Complement Pathways

open access: yesAllergy, Volume 81, Issue 9, Page 3171-3184, September 2026.
IL‐33 induces inflammatory gene signatures in eosinophils, characterised by the upregulation of cell surface markers, inflammatory mediators and regulatory factors, all of which were also observed in nasal polyp‐derived eosinophils. Ox‐LDL and complement fragments (C3a and C5a) promote eosinophil adhesion and survival.
Emiko Matsuyama   +16 more
wiley   +1 more source

Type‐2‐Inflammatory‐Diseases Share Comorbidities, Molecular Signatures, IL4/IL13 Genetics, and Response to IL4/IL13 Blockade

open access: yesAllergy, Volume 81, Issue 9, Page 3345-3360, September 2026.
Studies suggest that type 2 inflammatory diseases are driven by overactivation of the IL4/IL13 pathway, manifesting differently in distinct tissues. We performed quantitative analyses using several large independent datasets to explore the interrelation of type 2 inflammatory diseases based on co‐prevalence, genetic predispositions, and transcriptomic ...
Jennifer D. Hamilton   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy